Executive Summary:
In today’s global pharmaceutical landscape, outsourcing development and manufacturing to a Contract Development and Manufacturing Organization (CDMO) or Contract Manufacturing Organization (CMO) has become a strategic necessity.
Whether targeting the US, Europe, or Rest of the World (RoW) markets, selecting the right partner directly impacts product quality, timelines, regulatory success, and overall commercial outcomes and that is for a long term.
This article outlines in brief a structured, global approach to identifying, shortlisting, and selecting the right CDMO/CMO partner.
Step 1: Clearly Define Your Project Scope
Before initiating partner search, define:
• Type: API, formulation, or integrated services
• Stage: development, scale-up, or commercial manufacturing
• Target markets: USFDA, EMA, MHRA, WHO, etc.
• Complexity: injectable, oncology, controlled substances, novel delivery systems
A clearly defined scope ensures alignment with the right global CDMO capabilities.
Step 2: Build a Global Longlist of CDMO / CMO Partners
Identify potential partners through:
• Industry networks and referrals
• Global pharma conferences (e.g., CPhI, BIO, DCAT)
• Experts / Consultants / Consulting firms and databases Evaluate:
• Experience in similar product categories
• Regulatory track record across multiple markets
• Geographic footprint and scalability
Focus on creating a diverse global partner pool across regions.
Step 3: Technical Screening and Capability Fit
Shortlist partners based on:
• Manufacturing infrastructure and technologies
• R&D and development capabilities
• Compliance with international standards (USFDA, EMA, PIC/S, WHO-GMP)
Request:
• Company profile
• Inspection history
• Product pipeline / portfolio
This step helps identify technically aligned CDMO/CMO partners globally.
Step 4: Detailed Due Diligence and Quality Assessment
Conduct in-depth evaluation:
• Quality Management Systems (QMS)
• Data integrity and compliance practices
• Deviation handling and CAPA systems
• Analytical and stability capabilities
On-site or virtual audits are essential for ensuring global regulatory compliance.
Step 5: Commercial Evaluation and Value Analysis
Assess:
• Development and manufacturing costs
COGS / CCPC
• Technology transfer costs
• Timelines and scalability
• Contractual terms
Avoid decisions based solely on cost — prioritize long-term value, reliability, and compliance.
⸻
Step 6: Evaluate Communication and Project Management Strength
Effective collaboration is key in global pharma outsourcing.
Evaluate:
• Responsiveness and transparency
• Reporting structure and documentation
• Experience in managing international clients
Strong project management ensures smoother execution across geographies.
Step 7: Pilot Engagement (Where ever Feasible)
Before full-scale commitment:
• Initiate a pilot project or limited scope engagement
• Assess execution capability, timelines, and communication
This reduces risk in selecting a long-term strategic partner.
Step 8: Final Selection and Contracting
Finalize with:
• Clearly defined Scope of Work (SOW)
• Milestones and KPIs
• Quality agreements and confidentiality clauses
A robust agreement ensures alignment and accountability.
Conclusion
Selecting the right CDMO/CMO partner is not just an operational decision — it is a strategic partnership that influences product success across global markets.
A structured evaluation approach, combined with strong project management and due diligence, significantly enhances success rates.
How S&A PharmaProjects Can Support / Assist you…
With its expertise, experience and connections / association with more than 180 CDMOs /CMOs /CROs across all continents, S&A PharmaProjects can assist you in all above 8 steps – using its systematic, SOPs and Check List driven, strategic selection and Match Making activities.
S&A PharmaProjects supports global pharmaceutical and biotech companies by acting as a Strategic Consulting Partner, a System driven Match Maker and a Project Management Company with extended office, helping identify, evaluate, and manage CDMO/CMO partners across geographies.
Connect with us to identify the right partners and ensure seamless execution of your global pharma projects.
